July 12, 2012

CRH Medical To Present at Bloom Burton & Co. Healthcare Investor Conference

CRH Medical To Present at Bloom Burton & Co. Healthcare Investor Conference

VANCOUVER, B.C. – June 12, 2012 – CRH Medical Corporation – (TSX-V: CRM) (OTCQX: CRMMF), ), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that Edward Wright, the Company’s Chief Executive Officer, will present at the inaugural Bloom Burton & Co. Healthcare Investor Conference on Thursday, June 21, at 10:00 am Eastern Time. The conference will be held at the Toronto Board of Trade in Toronto, Ontario.

Mr. Wright will provide a corporate update, including information about the Company’s lead product, the CRH O’Regan System.

The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and European investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian public and private companies through presentations and break-out Q&A sessions.

About CRH Medical Corporation:

CRH Medical Corporation specializes in the distribution of innovative medical products directly to physicians, particularly those in the gastroenterologist community. The Company’s lead product, the CRH O’Regan System, is a single use, disposable, hemorrhoid treatment that is safe and highly effective in treating hemorrhoid grades I – IV. The O’Regan System is rapidly emerging as the standard of care with gastroenterologists who treat hemorrhoids. In addition to the product, CRH Medical delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its web-based platform to connect doctors with patients as well as educating its ever increasing install base of physicians.

About Bloom Burton & Co.:
Bloom Burton & Co. is Canada’s largest and most active healthcare-specialized investment banking group. The team of healthcare specialists merges scientific, medical, clinical, intellectual property and commercial expertise with a strong understanding of the capital markets, to advise and raise capital for private and public companies. For more information, please visit www.bloomburton.com.

For more information, please contact:

Edward Wright, Chief Executive Officer
CRH Medical Corporation
604.633.1440 x1008
ewright@crhmedcorp.com

or

Adam Peeler, Media and Investor Relations
TMX Equicom
416.815.0700 x 225

We're a stable, profitable company respected by both patients and physicians. Learn more »